Abstract:Gene amplifications and deletions frequently contribute to tumorigenesis. Characterization of these DNA copy-number changes is important for both the basic understanding of cancer and its diagnosis. Comparative genomic hybridization (CGH) was developed to survey DNA copy-number variations across a whole genome1. With CGH, differentially labelled test and reference genomic DNAs are co-hybridized to normal metaphase chromosomes, and fluorescence ratios along the length of chromosomes provide a cytogenetic representation of DNA copy-number variation. CGH, however, has a limited (~20 Mb) mapping resolution, and higher-resolution techniques, such as fluorescence in situ hybridization (FISH), are prohibitively labour-intensive on a genomic scale. Array-based CGH, in which fluorescence ratios at arrayed DNA elements provide a locus-by-locus measure of DNA copy-number variation, represents another means of achieving increased mapping resolution2,3,4. Published array CGH methods have relied on large genomic clone (for example BAC) array targets and have covered only a small fraction of the human genome. cDNAs representing over 30,000 radiation-hybrid (RH)–mapped human genes5,6 provide an alternative and readily available genomic resource for mapping DNA copy-number changes. Although cDNA microarrays have been used extensively to characterize variation in human gene expression7,8,9, human genomic DNA is a far more complex mixture than the mRNA representation of human cells. Therefore, analysis of DNA copy-number variation using cDNA microarrays would require a sensitivity of detection an order of magnitude greater than has been routinely reported7. We describe here a cDNA microarray-based CGH method, and its application to DNA copy-number variation analysis in breast cancer cell lines and tumours. Using this assay, we were able to identify gene amplifications and deletions genome-wide and with high resolution, and compare alterations in DNA copy number and gene expression.

Characterization of breast cancer by array comparative genomic hybridization.

Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression

Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization

Identification of cancer genes using a statistical framework for multi-experiment analysis of non-discretized array CGH data (vol 36, pg 13, 2008)

Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma

Array Comparative Genome Hybridization for Tumor Classification and Gene Discovery in Mouse Models of Malignant Melanoma.

Classification of arrayCGH data using a fused SVM

Statistical Methods for Detecting Genomic Alterations Through Array-Based Comparative Genomic Hybridization (CGH).

Advancement in Study on Comparative Genomic Hybridization

Chromosomal Aberrations Detected by Comparative Genomic Hybridization Predict Outcome in Patients with Colorectal Carcinoma

Classification of human cancer diseases by gene expression profiles

Combining chromosomal arm status and significantly aberrant genomic locations reveals new cancer subtypes

CGHTRIMMER: Discretizing noisy Array CGH Data

Application of Comparative Genomic Hybridization (CGH) in the Genetic Analysis of Lymphoma

Cancer cytogenetics in a genomics world: Wedding the old with the new

High-Resolution Array-Based Comparative Genomic Hybridization of Medulloblastomas and Supratentorial Primitive Neuroectodermal Tumors

Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.

Functional Genomic Analysis of Chromosomal Aberrations in a Compendium of 8000 Cancer Genomes